NRX Pharmaceuticals Newsroom

NRX Pharmaceuticals Price Target Raised to $45.00/Share From $44.00 by Ascendiant Capital

Dow JonesDec 2 04:48 ET

NRX Pharmaceuticals Is Maintained at Buy by Ascendiant Capital

Dow JonesDec 2 04:48 ET

NRX Pharmaceuticals Analyst Ratings

BenzingaNov 25 08:39 ET

NRX Pharmaceuticals Analyst Ratings

BenzingaOct 30 08:52 ET

NRX Pharmaceuticals Analyst Ratings

BenzingaSep 12 13:58 ET

HC Wainwright & Co. Maintains Buy on NRX Pharmaceuticals, Adjusts Price Target To $19 (1-10 Reverse Stock Split)

BenzingaAug 5 15:42 ET

NRX Pharmaceuticals Analyst Ratings

BenzingaAug 5 15:41 ET

NRX Pharmaceuticals Analyst Ratings

BenzingaJun 7 11:58 ET

Buy Rating Affirmed for NRX Pharmaceuticals Amid Promising Outlook for Novel Depression Treatment NRX-100

TipRanksJan 22 14:09 ET

Analysts Are Bullish on These Healthcare Stocks: HCA Healthcare (HCA), NRX Pharmaceuticals (NRXP)

TipRanksOct 24, 2023 09:50 ET

H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)

TipRanksMay 25, 2023 06:15 ET

HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target

BenzingaMay 25, 2023 06:07 ET

Ascendiant Remains a Buy on NRX Pharmaceuticals (NRXP)

TipRanksApr 7, 2023 04:20 ET

H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)

TipRanksFeb 2, 2023 12:20 ET

NRX Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsFeb 2, 2023 12:18 ET

HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target

Benzinga Real-time NewsFeb 2, 2023 12:18 ET

H.C. Wainwright Remains a Buy on NRX Pharmaceuticals (NRXP)

TipRanksJan 19, 2023 09:20 ET

Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP) and Arcutis Biotherapeutics (ARQT)

TipRanksNov 15, 2022 09:58 ET

NRX Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsNov 9, 2022 06:22 ET

Ascendiant Capital Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $4

Benzinga Real-time NewsNov 9, 2022 06:22 ET